Cybrexa Therapeutics Announces Expansion of Its Anticancer Pipeline
09 déc. 2019 08h30 HE
|
Cybrexa Therapeutics
NEW HAVEN, Conn., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a biotechnology company developing a new class of cancer therapeutics through its alphalex™ tumor targeting platform, today...